Trial Outcomes & Findings for Association of Acupuncture and Cupping in Advanced Knee Osteoarthritis (NCT NCT04168593)

NCT ID: NCT04168593

Last Updated: 2025-03-27

Results Overview

Western Ontario and McMaster Universities Osteoarthritis Womac-Pain section. Score: 0 (no pain) to 20 (worse condition)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

120 participants

Primary outcome timeframe

value collected at 5 week

Results posted on

2025-03-27

Participant Flow

recruitment by phone from a list of patients with advanced KOA who is waiting for a TKR. the inclusion criteria is applied.

by phone we applied the WOMAC-Pain and invite who have 15 points or more

Participant milestones

Participant milestones
Measure
A- Acupuncture Sham + Cupping Sham
Sham acupuncture: Placement of placebo "dagger" needles. The needle tip, when touching the patient's skin, retracts into itself without puncturing the skin. Application locations: LI11, SP9, SP10, LR8, GB34, ST34, Ex-LE5. Running time of 20 minutes. Sham cupping: after each acupuncture session (Sham or True), the respective needles were removed, and acrylic suction cups were placed over the region where the needles were, attached to a strip (micropore) without exerting any negative pressure or movement. Application time of 10 minutes.
B -Sham Acupuncture + Real Cupping
Acupuncture 20 min of Acupuncture section follow by 10 min of cupping around the knee
C - Real Acupuncture + Sham Cupping
20 min of Acupuncture section follow by 10 min of cupping around the knee
D - Real Acupuncture + Real Cupping
20 min of Acupuncture section follow by 10 min of cupping around the knee
Overall Study
STARTED
30
30
30
30
Overall Study
COMPLETED
26
28
27
29
Overall Study
NOT COMPLETED
4
2
3
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
A- Placebo
n=30 Participants
Sham Acupuncture and Sham Cupping 20 min of Acupuncture section using placebo needle follow by 10 min of cupping sham (no negative pressure) around the knee
B -Cupping
n=30 Participants
Sham Acupuncture and Real Cupping 20 min of Acupuncture section using placebo needle follow by 10 min of real cupping around the knee
C - Acupuncture
n=30 Participants
Real Acupuncture and Sham Cupping 20 min of Real Acupuncture section follow by 10 min of sham cupping around the knee
D - Acupuncture + Cupping
n=30 Participants
Real Acupuncture and Real Cupping 20 min of Real Acupuncture section follow by 10 min of real cupping around the knee
Total
n=120 Participants
Total of all reporting groups
Age, Customized
Age distribution
66.1 years
STANDARD_DEVIATION 10.88 • n=30 Participants
66.1 years
STANDARD_DEVIATION 10.86 • n=30 Participants
68.1 years
STANDARD_DEVIATION 11.15 • n=30 Participants
66.8 years
STANDARD_DEVIATION 8.09 • n=30 Participants
66.8 years
STANDARD_DEVIATION 10.17 • n=120 Participants
Sex: Female, Male
Female
21 Participants
n=30 Participants
23 Participants
n=30 Participants
23 Participants
n=30 Participants
25 Participants
n=30 Participants
92 Participants
n=120 Participants
Sex: Female, Male
Male
9 Participants
n=30 Participants
7 Participants
n=30 Participants
7 Participants
n=30 Participants
5 Participants
n=30 Participants
28 Participants
n=120 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
Brazil
30 participants
n=30 Participants
30 participants
n=30 Participants
30 participants
n=30 Participants
30 participants
n=30 Participants
120 participants
n=120 Participants
WOMAC-Pain
16.83 units on a scale
STANDARD_DEVIATION 1.74 • n=30 Participants
16.50 units on a scale
STANDARD_DEVIATION 1.38 • n=30 Participants
16.40 units on a scale
STANDARD_DEVIATION 1.43 • n=30 Participants
16.90 units on a scale
STANDARD_DEVIATION 1.75 • n=30 Participants
16.66 units on a scale
STANDARD_DEVIATION 1.58 • n=120 Participants
VAS
84.03 units on a scale
STANDARD_DEVIATION 13.75 • n=30 Participants
89.57 units on a scale
STANDARD_DEVIATION 11.81 • n=30 Participants
82.83 units on a scale
STANDARD_DEVIATION 12.97 • n=30 Participants
91.30 units on a scale
STANDARD_DEVIATION 11.43 • n=30 Participants
89.92 units on a scale
STANDARD_DEVIATION 12.88 • n=120 Participants

PRIMARY outcome

Timeframe: value collected at 5 week

Population: We used the concept of Intent to Treat (ITT) for statistical analysis purposes, that is, all recruited participants, even if they did not complete the proposed 10-session treatment, were included in the final analysis

Western Ontario and McMaster Universities Osteoarthritis Womac-Pain section. Score: 0 (no pain) to 20 (worse condition)

Outcome measures

Outcome measures
Measure
Group A
n=30 Participants
Sham Acupuncture + Sham Cupping
Group B
n=30 Participants
Sham Acupuncture + Real Cupping
Group C
n=30 Participants
Real Acupuncture + Sham Cupping
Group D
n=30 Participants
Real Acupuncture + Real Cupping
Group D
Real Acupuncture + Real Cupping
WOMAC - Pain
11.60 units on a scale
Standard Deviation 4.17
11.30 units on a scale
Standard Deviation 4.23
10.80 units on a scale
Standard Deviation 4.64
9.83 units on a scale
Standard Deviation 4.76

PRIMARY outcome

Timeframe: Value collected at 5 weeks

Population: We used the concept of Intent to Treat (ITT) for statistical analysis purposes, that is, all recruited participants, even if they did not complete the proposed 10-session treatment, were included in the final analysis.

Intensity of pain 0-100 mm (0 corresponds to a better condition, otherwise, 100 correspond to a worst condition of pain)

Outcome measures

Outcome measures
Measure
Group A
n=30 Participants
Sham Acupuncture + Sham Cupping
Group B
n=30 Participants
Sham Acupuncture + Real Cupping
Group C
n=30 Participants
Real Acupuncture + Sham Cupping
Group D
n=30 Participants
Real Acupuncture + Real Cupping
Group D
Real Acupuncture + Real Cupping
VAS
67.43 units on a scale
Standard Deviation 23.09
61.57 units on a scale
Standard Deviation 25.57
47.87 units on a scale
Standard Deviation 27.23
47.43 units on a scale
Standard Deviation 28.99

SECONDARY outcome

Timeframe: Number of Participants with reduction in the use of pain medications after protocol (at 5 week)

Population: We used the concept of Intent to Treat (ITT) for statistical analysis purposes, that is, all recruited participants, even if they did not complete the proposed 10-session treatment, were included in the final analysis.

number of pills per day For each group, those who had a reduction in the use of pain medications (analgesics and/or anti-inflammatory drugs) we described as Y (yes), and those who maintained or even increased the amount or simply did not return such information we described as N (no).

Outcome measures

Outcome measures
Measure
Group A
n=120 Participants
Sham Acupuncture + Sham Cupping
Group B
n=30 Participants
Sham Acupuncture + Real Cupping
Group C
n=30 Participants
Real Acupuncture + Sham Cupping
Group D
n=30 Participants
Real Acupuncture + Real Cupping
Group D
n=30 Participants
Real Acupuncture + Real Cupping
Analgesic Consumption
72 Participants
12 Participants
18 Participants
19 Participants
23 Participants

Adverse Events

Group A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Group B

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Group C

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Group D

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Group A
n=30 participants at risk
Sham + Sham
Group B
n=30 participants at risk
Sham Acp + Real Cupping
Group C
n=30 participants at risk
Real ACP + Sham Cupping
Group D
n=30 participants at risk
Real + Real
Skin and subcutaneous tissue disorders
hematoma
0.00%
0/30 • after 5 weeks from initial treatment
no serious adverse event, only local hematoma
3.3%
1/30 • after 5 weeks from initial treatment
no serious adverse event, only local hematoma
6.7%
2/30 • after 5 weeks from initial treatment
no serious adverse event, only local hematoma
6.7%
2/30 • after 5 weeks from initial treatment
no serious adverse event, only local hematoma

Additional Information

Andre Wan Wen Tsai

USaoPauloGH

Phone: 5511981456449

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place